Successful sale of BRAHMS in an all cash transaction to Thermo Fisher
Scientific leads to NAV increase of CHF 8.88, or 15.5%
04-Sep-2009 -
Thermo Fisher Scientific Inc. and BRAHMS Holding GmbH announced the signing of a definitive Share Purchase Agreement. Under the terms of the agreement Thermo Fisher Scientific will acquire all issued shares of BRAHMS for a gross purchase price of EUR 330 million (approximately USD 470 million), ...
biomarkers
regulatory approval
Thermo Fisher Scientific